Neumora Therapeutics, Inc. Financial Flexibility Index
Neumora Therapeutics, Inc. financial flexibility index. Neumora Therapeutics, Inc. (NMRA) has a Financial Flexibility Index of -1.02x as of September 2025. Free cash flow of $-46.62 Million (operating CF $-46.63 Million minus capex $16.00K) represents -1% of total liabilities ($45.67 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Neumora Therapeutics, Inc. (2019–2024)
Financial flexibility index of Neumora Therapeutics, Inc. from 2019 to 2024. Historical Financial Flexibility Index trend for Neumora Therapeutics, Inc. across 6 annual periods. Explore Neumora Therapeutics, Inc. (NMRA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Neumora Therapeutics, Inc. Financial Flexibility Index by Year (2019–2024)
Neumora Therapeutics, Inc. financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Neumora Therapeutics, Inc.. For the full cash flow conversion analysis, see how efficiently does Neumora Therapeutics, Inc. generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.12x | $-182.94 Million | $-182.94 Million | $29.91 Million | ▼ -1.7% |
| 2023 | -6.02x | $-163.16 Million | $-163.28 Million | $27.12 Million | ▼ -4492.3% |
| 2022 | -0.13x | $-114.39 Million | $-114.90 Million | $873.08 Million | ▼ -32.5% |
| 2021 | -0.10x | $-74.60 Million | $-75.42 Million | $754.52 Million | ▼ -13.5% |
| 2020 | -0.09x | $-25.46 Million | $-26.76 Million | $292.33 Million | ▲ +100.0% |
| 2019 | -1212.38x | $-25.46 Million | $-26.76 Million | $21.00K | — |